José Fabián Martínez-Herrera, Gisela Sánchez Domínguez, Juan J Juárez-Vignon Whaley, Sonia Carrasco-Cara Chards, Claudia López Vrátný, Jordi Guzmán Casta, Rodrigo F Riera Sala, Jorge A Alatorre-Alexander, Alec Seidman Sorsby, Mayte Cruz Zermeño, Emilio Conde Flores, Rodrigo R Flores-Mariñelarena, Carla P Sánchez-Ríos, Luis M Martínez-Barrera, Raquel Gerson-Cwilich, Patricio Santillán-Doherty, José C Jiménez López, William López Hernández, Jerónimo R Rodríguez-Cid
BACKGROUND: Lung cancer represents a significant global health concern, often diagnosed in its advanced stages. The advent of massive DNA sequencing has revolutionized the landscape of cancer treatment by enabling the identification of target mutations and the development of tailored therapeutic approaches. Unfortunately, access to DNA sequencing technology remains limited in many developing countries. In this context, we emphasize the critical importance of integrating this advanced technology into healthcare systems in developing nations to improve treatment outcomes...
January 30, 2024: Journal of Thoracic Disease